当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:158.62亿  总市值:158.68亿
流通股本:11.69亿   总股本:11.69亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,047,554,062.499,716,872,993.657,470,804,774.825,192,153,998.21
收到的税费返还129,949,532.27426,914,185.73377,272,002.48247,591,936.77
收到其他与经营活动有关的现金50,168,005.63267,682,607.59235,141,089.55134,817,924.16
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,227,671,600.3910,411,469,786.978,083,217,866.855,574,563,859.14
购买商品、接受劳务支付的现金1,549,400,995.386,954,988,912.155,241,010,944.553,404,063,083.55
支付给职工以及为职工支付的现金334,857,072.87994,709,846.91668,301,144.09487,665,390.82
支付的各项税费188,779,313.84453,982,711.64408,642,692.37326,140,618.77
支付其他与经营活动有关的现金169,627,687.46799,034,633.26599,553,971375,913,491.52
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,242,665,069.559,202,716,103.966,917,508,752.014,593,782,584.66
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-14,993,469.161,208,753,683.011,165,709,114.84980,781,274.48
二、投资活动产生的现金流量:
收回投资收到的现金229,954,791.43860,292,262.61209,817,558.38-
取得投资收益收到的现金10,468,676.8919,600,000--
处置固定资产、无形资产和其他长期资产收回的现金净额814,711.048,513,207.312,140,8791,311,425.61
处置子公司及其他营业单位收到的现金净额30,054,923.337,600,0007,600,0007,600,000
收到的其他与投资活动有关的现金-2,620,59923,888,979.9723,819,070.2
投资活动现金流入的平衡项目0000
投资活动现金流入小计271,293,102.69898,626,068.92243,447,417.3532,730,495.81
购建固定资产、无形资产和其他长期资产支付的现金125,815,890.84460,745,527.76370,821,462.29225,470,429.51
投资支付的现金236,847,900825,532,427.56205,532,427.566,000,000
支付其他与投资活动有关的现金-10,359,84631,631,603.7122,527,412.28
投资活动现金流出的平衡项目0000
投资活动现金流出小计362,663,790.841,296,637,801.32607,985,493.56253,997,841.79
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-91,370,688.15-398,011,732.4-364,538,076.21-221,267,345.98
三、筹资活动产生的现金流量:
吸收投资收到的现金-505,050505,050505,050
其中:子公司吸收少数股东投资收到的现金-505,050505,050505,050
取得借款收到的现金296,900,0001,388,380,014.791,005,000,000530,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计296,900,0001,388,885,064.791,005,505,050530,505,050
偿还债务支付的现金320,100,0001,405,844,000974,844,000463,944,000
分配股利、利润或偿付利息支付的现金6,765,243.37401,629,843.49400,949,056.95392,174,429.92
支付其他与筹资活动有关的现金1,431,062.9163,562,602.42162,242,683.59152,684,774.7
筹资活动现金流出平衡项目0000
筹资活动现金流出小计328,296,306.271,971,036,445.911,538,035,740.541,008,803,204.62
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-31,396,306.27-582,151,381.12-532,530,690.54-478,298,154.62
四、汇率变动对现金及现金等价物的影响3,246,242.9338,368,228.834,431,426.1331,181,409.14
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-134,514,220.65266,958,798.32273,071,774.22312,397,183.02
加:期初现金及现金等价物余额2,729,444,560.062,462,485,761.742,462,485,761.742,462,485,761.74
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,594,930,339.412,729,444,560.062,735,557,535.962,774,882,944.76
补充资料:
净利润-1,030,846,722.3-624,645,137.35
资产减值准备-69,303,010.56-92,493,877.92
固定资产和投资性房地产折旧-566,863,534.09-271,502,187.29
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-566,863,534.09-271,502,187.29
无形资产摊销-11,154,526.62-5,569,667.1
长期待摊费用摊销-6,253,865.47-3,651,259.63
处置固定资产、无形资产和其他长期资产的损失--279,470.84--567,328.49
固定资产报废损失-8,368,983.61-1,244,290.9
公允价值变动损失--7,965,391.23-2,535,659.78
财务费用--5,344,052.9--46,536,961.35
投资损失-1,753,932.65-723,423.58
递延所得税-1,009,201.3-15,099,049.09
其中:递延所得税资产减少-19,740,749.8-24,612,161.01
递延所得税负债增加--18,731,548.5--9,513,111.92
存货的减少-152,988,779.49-332,492,337.48
经营性应收项目的减少--251,453,661.58--650,389,770.25
经营性应付项目的增加--375,303,021.38-321,711,320.17
其他-556,724.85--
现金的期末余额-2,729,444,560.06-2,774,882,944.76
减:现金的期初余额-2,462,485,761.74-2,462,485,761.74
公告日期2025-04-182025-03-112024-10-182024-08-16
审计意见(境内)标准无保留意见
TOP↑